Paloma Partners’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-14,021
| Closed | -$135K | – | 1980 |
|
|
2020
Q3 | $135K | Buy |
+14,021
| New | +$135K | ﹤0.01% | 1684 |
|
|
2017
Q1 | – | Sell |
-52,823
| Closed | -$843K | – | 1695 |
|
|
2016
Q4 | $843K | Buy |
52,823
+10,190
| +24% | +$163K | 0.01% | 857 |
|
|
2016
Q3 | $710K | Buy |
42,633
+25,483
| +149% | +$424K | 0.01% | 803 |
|
|
2016
Q2 | $192K | Buy |
+17,150
| New | +$192K | ﹤0.01% | 1544 |
|
|
2015
Q2 | – | Sell |
-21,525
| Closed | -$200K | – | 1711 |
|
|
2015
Q1 | $200K | Buy |
+21,525
| New | +$200K | 0.01% | 973 |
|
|
2014
Q4 | – | Sell |
-24,961
| Closed | -$259K | – | 1267 |
|
|
2014
Q3 | $259K | Buy |
+24,961
| New | +$259K | 0.01% | 699 |
|